Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
4.700
+0.100 (2.17%)
At close: Apr 13, 2026, 4:00 PM EDT
4.738
+0.038 (0.81%)
After-hours: Apr 13, 2026, 7:24 PM EDT
Nuvation Bio Employees
Nuvation Bio had 298 employees as of December 31, 2025. The number of employees increased by 78 or 35.45% compared to the previous year.
Employees
298
Change (1Y)
78
Growth (1Y)
35.45%
Revenue / Employee
$211,081
Profits / Employee
-$686,668
Market Cap
1.61B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 298 | 78 | 35.45% |
| Dec 31, 2024 | 220 | 169 | 331.37% |
| Dec 31, 2023 | 51 | -2 | -3.77% |
| Dec 31, 2022 | 53 | -11 | -17.19% |
| Dec 31, 2021 | 64 | 28 | 77.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Iovance Biotherapeutics | 975 |
| Immunocore Holdings | 524 |
| Ardelyx | 489 |
| Intellia Therapeutics | 377 |
| Vir Biotechnology | 367 |
| Nurix Therapeutics | 317 |
| Harmony Biosciences Holdings | 293 |
| Viridian Therapeutics | 252 |
NUVB News
- 12 days ago - Nuvation Bio Announces Acquisition of Japan Rights to Safusidenib from Daiichi Sankyo - PRNewsWire
- 18 days ago - Eisai and Nuvation Bio Announce Marketing Authorisation Application for Taletrectinib for the Treatment of Advanced ROS1-Positive Non-Small Cell Lung Cancer Validated by the European Medicines Agency - PRNewsWire
- 23 days ago - NUVB Investors Have Opportunity to Join Nuvation Bio Inc. Fraud Investigation with the Schall Law Firm - Business Wire
- 27 days ago - Nuvation Bio to Present Pivotal IBTROZI® (Taletrectinib) Data in TKI-Naïve and TKI-Pretreated Patients with Advanced ROS1-Positive Non-Small Cell Lung Cancer at AACR 2026 - PRNewsWire
- 5 weeks ago - Nuvation Bio Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses - GlobeNewsWire
- 6 weeks ago - Nuvation Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - PRNewsWire
- 6 weeks ago - Nuvation Bio to Participate in Upcoming Investor Conferences - PRNewsWire
- 7 weeks ago - Nuvation Bio to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 2, 2026 - PRNewsWire